Alfacalcidol shortage — FR supply status & alternatives

Alfacalcidol

ATC A11CC03

In supply · Australia

Un-Alfa

In supply · 🇦🇺 Australia · short in🇫🇷 FR🇨🇦 CA🇮🇹 IT🇳🇿 NZ🇧🇪 BE🇳🇱 NL

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Brand names
Active ingredient (INN)	Alfacalcidol

ATC level 5	A11CC03

ATC level 4	A11CC

Therapeutic category	Auto-created by Agence nationale de sécurité du médicament — Disponibilité scraper

Controlled substance	No

Marketing-authorisation holders	STRIDES PHARMA UK LIMITED, NEON HEALTHCARE LIMITED, SANDOZ CANADA INCORPORATED, STRIDES PHARMA CANADA INC

Registrations on file	7

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Other markets

🇫🇷 FR

€12.43

Retail price

🇪🇸 ES

€9.04

Retail price

🇬🇧 GB

£2.56

Drug Tariff

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇫🇷

France

ANSM · 5d ago

High

🇳🇿

New Zealand

Pharmac · 12d ago

High

🇨🇦

Canada

HC · 5h ago

Medium

🇮🇹

Italy

AIFA · 1d ago

Medium

🇳🇱

Netherlands

CBG-MEB · 2d ago

Medium

🇧🇪

FAMHP · 3mo ago

Medium

Verified timeline regulator events

🇫🇷 13 May 2026

Shortage resolved

🇫🇷 25 Mar 2026

Shortage resolved

🇳🇿 25 Mar 2026

high reported

🇳🇱 23 Mar 2026

medium reported

🇧🇪 17 Mar 2026

medium reported

🇳🇿 12 Mar 2026

high reported

Sources official regulators

🇨🇦

verified 5h ago

verify ↗

🇮🇹

AIFA

verified 1d ago

verify ↗

🇫🇷

ANSM

verified 1d ago

verify ↗

🇳🇱

CBG-MEB

verified 2d ago

verify ↗

🇳🇿

Pharmac

verified 12d ago

verify ↗

🇧🇪

FAMHP

verified 3mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders7 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
ALFACALCIDOL 0.25 MICROGRAM CAPSULES, SOFT	0.25 MICROGRAM	capsule	🇬🇧 GB	STRIDES PHARMA UK LIMITED	Active
ALFACALCIDOL 0.5 MICROGRAM CAPSULES, SOFT	0.5 MICROGRAM	capsule	🇬🇧 GB	STRIDES PHARMA UK LIMITED	Active
ALFACALCIDOL 1.0 MICROGRAM CAPSULES, SOFT	1.0 MICROGRAM	capsule	🇬🇧 GB	STRIDES PHARMA UK LIMITED	Active
ALFACALCIDOL CAPSULES 0.25 MICROGRAM	0.25 MICROGRAM	capsule	🇬🇧 GB	NEON HEALTHCARE LIMITED	Active
ALFACALCIDOL CAPSULES 1.0 MICROGRAM	1.0 MICROGRAM	capsule	🇬🇧 GB	NEON HEALTHCARE LIMITED	Active
Sandoz Alfacalcidol	—	capsule	🇨🇦 CA	SANDOZ CANADA INCORPORATED	Active
ALFACALCIDOL CAPSULES	—	capsule	🇨🇦 CA	STRIDES PHARMA CANADA INC	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.